200 related articles for article (PubMed ID: 31838328)
1. Design, synthesis and discovery of andrographolide derivatives against Zika virus infection.
Li F; Lee EM; Sun X; Wang D; Tang H; Zhou GC
Eur J Med Chem; 2020 Feb; 187():111925. PubMed ID: 31838328
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide and Its 14-Aryloxy Analogues Inhibit Zika and Dengue Virus Infection.
Li F; Khanom W; Sun X; Paemanee A; Roytrakul S; Wang D; Smith DR; Zhou GC
Molecules; 2020 Oct; 25(21):. PubMed ID: 33143016
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of zika virus infection by fused tricyclic derivatives of 1,2,4,5-tetrahydroimidazo[1,5-a]quinolin-3(3aH)-one.
Xu B; Lee EM; Medina A; Sun X; Wang D; Tang H; Zhou GC
Bioorg Chem; 2020 Nov; 104():104205. PubMed ID: 32916389
[TBL] [Abstract][Full Text] [Related]
4. Optimization of 1,3-disubstituted urea-based inhibitors of Zika virus infection.
Khachatoorian R; Micewicz ED; Micewicz A; French SW; Ruchala P
Bioorg Med Chem Lett; 2019 Oct; 29(20):126626. PubMed ID: 31477351
[TBL] [Abstract][Full Text] [Related]
5. Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds.
Kaptein SJF; Vincetti P; Crespan E; Rivera JIA; Costantino G; Maga G; Neyts J; Radi M
ChemMedChem; 2018 Jul; 13(14):1371-1376. PubMed ID: 29740962
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of baicalein derivatives and evaluation of their antiviral activity against arboviruses.
Qian XJ; Zhou HY; Liu Y; Dong JX; Tang WD; Zhao P; Tang HL; Jin YS
Bioorg Med Chem Lett; 2022 Sep; 72():128863. PubMed ID: 35738350
[TBL] [Abstract][Full Text] [Related]
7. The A-Z of Zika drug discovery.
Mottin M; Borba JVVB; Braga RC; Torres PHM; Martini MC; Proenca-Modena JL; Judice CC; Costa FTM; Ekins S; Perryman AL; Horta Andrade C
Drug Discov Today; 2018 Nov; 23(11):1833-1847. PubMed ID: 29935345
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Discovery of N,N'-Carbazoyl-aryl-urea Inhibitors of Zika NS5 Methyltransferase and Virus Replication.
Spizzichino S; Mattedi G; Lauder K; Valle C; Aouadi W; Canard B; Decroly E; Kaptein SJF; Neyts J; Graham C; Sule Z; Barlow DJ; Silvestri R; Castagnolo D
ChemMedChem; 2020 Feb; 15(4):385-390. PubMed ID: 31805205
[TBL] [Abstract][Full Text] [Related]
9. Future and Perspectives of the Zika Virus: Drug Repurposing as a Powerful Tool for Treatment Insights.
Rampini D; Prieto DC; Colzi AL; de Araújo RV; Giarolla J
Mini Rev Med Chem; 2020; 20(18):1917-1928. PubMed ID: 32651967
[TBL] [Abstract][Full Text] [Related]
10. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel small-molecule inhibitors of Zika virus infection.
Micewicz ED; Khachatoorian R; French SW; Ruchala P
Bioorg Med Chem Lett; 2018 Feb; 28(3):452-458. PubMed ID: 29258771
[TBL] [Abstract][Full Text] [Related]
12. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.
Baltina LA; Lai HC; Liu YC; Huang SH; Hour MJ; Baltina LA; Nugumanov TR; Borisevich SS; Khalilov LM; Petrova SF; Khursan SL; Lin CW
Bioorg Med Chem; 2021 Jul; 41():116204. PubMed ID: 34022526
[TBL] [Abstract][Full Text] [Related]
14. Indole alkaloids inhibit zika and chikungunya virus infection in different cell lines.
Monsalve-Escudero LM; Loaiza-Cano V; Pájaro-González Y; Oliveros-Díaz AF; Diaz-Castillo F; Quiñones W; Robledo S; Martinez-Gutierrez M
BMC Complement Med Ther; 2021 Aug; 21(1):216. PubMed ID: 34454481
[TBL] [Abstract][Full Text] [Related]
15. Discovery of dehydroandrographolide derivatives with C19 hindered ether as potent anti-ZIKV agents with inhibitory activities to MTase of ZIKV NS5.
Qian W; Zhou GF; Ge X; Xue JX; Zheng CB; Yang LM; Gu XR; Li C; Xiong SD; Zheng YT; Zhou GC
Eur J Med Chem; 2022 Dec; 243():114710. PubMed ID: 36055002
[TBL] [Abstract][Full Text] [Related]
16. 2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine.
Barbosa-Lima G; Moraes AM; Araújo ADS; da Silva ET; de Freitas CS; Vieira YR; Marttorelli A; Neto JC; Bozza PT; de Souza MVN; Souza TML
Eur J Med Chem; 2017 Feb; 127():334-340. PubMed ID: 28068604
[TBL] [Abstract][Full Text] [Related]
17. Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus.
Martinez-Lopez A; Persaud M; Chavez MP; Zhang H; Rong L; Liu S; Wang TT; Sarafianos SG; Diaz-Griffero F
EBioMedicine; 2019 Sep; 47():269-283. PubMed ID: 31501074
[TBL] [Abstract][Full Text] [Related]
18. Current Breakthroughs in Structure-based Design of Synthetic and Natural Sourced Inhibitors Against Zika Viral Targets.
Nandi S; Kaur R; Kumar M; Sharma A; Naaz A; Mandal SC
Curr Top Med Chem; 2018; 18(20):1792-1803. PubMed ID: 30465510
[TBL] [Abstract][Full Text] [Related]
19. The Polyphenol-Rich Extract from
Clain E; Haddad JG; Koishi AC; Sinigaglia L; Rachidi W; Desprès P; Duarte Dos Santos CN; Guiraud P; Jouvenet N; El Kalamouni C
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991717
[TBL] [Abstract][Full Text] [Related]
20. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
